St. James Hospital

Dublin, Leinster DO8C9X2

1 studies enrolling now · 3 studies all time

What they study most

Endometrioid Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, HER2-Positive Primary Breast Cancer, Primary Peritoneal, Residual Invasive Breast Cancer, Sickle Cell Disease

Studies at this site

• CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. — Recruiting now
• A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD) — Running, not enrolling
• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling